The balance seems to be shifting at Bayer AG. By buying Monsanto Co., the German company would see its crop-science unit surpass pharmaceuticals in sales. The health-care business generated about 44 percent of sales last year, more than any other Bayer division.
Before it's here, it's on the Bloomberg Terminal. LEARN MORE